Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
56
ANF Quote, Financials, Valuation and Earnings
Last price:
$154.61
Seasonality move
:
16.57%
Day range:
$151.00 - $159.83
52-week range:
$86.91 - $196.99
Dividend yield:
0%
P/E ratio:
15.29x
P/S ratio:
1.72x
P/B ratio:
6.24x
Volume:
3.5M
Avg. volume:
2M
1-year change:
71.94%
Market cap:
$7.8B
Revenue:
$4.3B
EPS (TTM):
$10.11
Earnings Data
Next earnings date for ANF
Mar 06
2025
Most recent earnings per share
$2.50
Beat by $0.15
(Nov 26/2024)
Consensus Estimate
$2.35
(Nov 26/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ANF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/06/2025 | Q1 | $1.6B | -- | -- | $3.54 | -- |
| 11/26/2024 | Q4 | $1.2B | $1.2B | $2.50 | $2.35 | $0.15 |
| 08/28/2024 | Q3 | $1.1B | $1.1B | $2.50 | $2.22 | $0.28 |
| 05/29/2024 | Q2 | $965M | $1B | $2.14 | $1.72 | $0.42 |
| 03/06/2024 | Q1 | $1.4B | $1.5B | $2.97 | $2.85 | $0.12 |
| 11/21/2023 | Q4 | -- | -- | $1.83 | $1.18 | $0.65 |
| 08/23/2023 | Q3 | -- | -- | $1.10 | $0.17 | $0.93 |
| 05/24/2023 | Q2 | -- | -- | $0.32 | $0.05 | $0.27 |
| 02/23/2023 | Q1 | -- | -- | $0.75 | $0.86 | -$0.11 |
| 11/22/2022 | Q4 | -- | -- | -$0.04 | -$0.12 | $0.08 |
| 08/25/2022 | Q3 | -- | -- | -$0.33 | $0.23 | -$0.56 |
| 05/24/2022 | Q2 | -- | -- | -$0.32 | $0.08 | -$0.40 |
| 03/02/2022 | Q1 | -- | -- | $1.12 | $1.27 | -$0.15 |
| 11/23/2021 | Q4 | -- | -- | $0.77 | $0.66 | $0.11 |
| 08/26/2021 | Q3 | -- | -- | $1.69 | $0.76 | $0.93 |
| 05/26/2021 | Q2 | -- | -- | $0.64 | -$0.38 | $1.02 |
| 03/02/2021 | Q1 | -- | -- | $1.27 | $1.23 | $0.04 |
| 11/24/2020 | Q4 | -- | -- | $0.66 | -$0.01 | $0.67 |
| 08/27/2020 | Q3 | -- | -- | $0.09 | -$0.83 | $0.92 |
| 06/04/2020 | Q2 | -- | -- | -$3.90 | -$1.20 | -$2.70 |
| 03/04/2020 | Q1 | -- | -- | $1.29 | $1.23 | $0.06 |
| 11/26/2019 | Q4 | -- | -- | $0.10 | $0.24 | -$0.14 |
| 08/29/2019 | Q3 | -- | -- | -$0.48 | -$0.52 | $0.04 |
| 05/29/2019 | Q2 | -- | -- | -$0.29 | -$0.43 | $0.14 |
| 03/06/2019 | Q1 | -- | -- | $1.35 | $1.15 | $0.20 |
| 11/29/2018 | Q4 | -- | -- | $0.33 | $0.21 | $0.12 |
| 08/30/2018 | Q3 | -- | -- | $0.06 | -$0.04 | $0.10 |
| 06/01/2018 | Q2 | -- | -- | -$0.56 | -$0.77 | $0.21 |
| 03/07/2018 | Q1 | -- | -- | $1.38 | $1.10 | $0.28 |
| 11/17/2017 | Q4 | -- | -- | $0.30 | $0.21 | $0.09 |
| 08/24/2017 | Q3 | -- | -- | -$0.16 | -$0.33 | $0.17 |
| 05/25/2017 | Q2 | -- | -- | -$0.72 | -$0.70 | -$0.02 |
| 03/02/2017 | Q1 | -- | -- | $0.76 | $0.74 | $0.02 |
| 11/18/2016 | Q4 | -- | -- | $0.02 | $0.19 | -$0.17 |
| 08/30/2016 | Q3 | -- | -- | -- | -- | -- |
| 05/26/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/02/2016 | Q1 | -- | -- | $1.08 | $0.96 | $0.12 |
| 11/20/2015 | Q4 | -- | -- | $0.48 | $0.19 | $0.29 |
| 08/26/2015 | Q3 | -- | -- | $0.12 | -- | -- |
| 05/28/2015 | Q2 | -- | -- | -- | -- | -- |
| 03/04/2015 | Q1 | -- | -- | $1.15 | $1.13 | $0.02 |
Abercrombie & Fitch Earnings Questions
-
How Much did Abercrombie & Fitch Generate in Revenue Last Quarter?
Abercrombie & Fitch reported $1.2B worth of top line sales in its most recent quarter.
-
Did Abercrombie & Fitch Beat Earnings Last Quarter?
Abercrombie & Fitch announced earnings per share of $2.50 which represents a beat of analyst forecast a $2.35 per share.
-
Is Abercrombie & Fitch Profitable?
Abercrombie & Fitch reported $786.9M that represents $14.88 per share over the last quarter.
-
What is the Analyst Consensus for Abercrombie & Fitch EPS Next Year?
Abercrombie & Fitch's earnings are forecast to grow from $6.22 per share to $6.14 per share next year representing an increase of 70.99%.
-
When is Abercrombie & Fitch's Earnings Date?
Abercrombie & Fitch's next earnings date is March 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
